Join our upcoming MPE and ASCERTAIN webinar on cost-effectiveness analysisMPE, Myeloma23 September 2025
Shape your myeloma care: New MPE research highlights the power of shared decision-making in myeloma careMPE, Myeloma, Patient evidence2 September 2025
The European Commission grants final authorisation for isatuximab (Sarclisa®) for transplant eligible newly diagnosed myeloma patientsMPE25 July 2025
Register now to join the webinar ‘How do different countries make decisions on reimbursing new medicines?’Access, MPE6 March 2025
MPE member spotlight: Fundacja Carita´s European Forum of Haemato-Oncological PatientsMPE, News6 February 2025
